Sanofi nanobody drug first approved to treat rare blood disorder
A year after Sanofi acquired nanobody producer, Ablynx, the deal has achieved its first success, with the US FDA approval of Cablivi.
Archives for February 7, 2019
Teva highlights quarterly dosing of migraine med as EU gives positive opinion
After a CHMP positive opinion, Teva’s Ajovy looks set to receive final approval to enter the EU market in the coming months.
RNAi research blooms with yeast-based production
Renaissance BioScience enters a partnership with Mitacs to test its yeast-based, RNAi production platform for biocontrol and biotherapeutics applications.